{
 "about": "One funder page of the Alleviate Index: a US foundation’s grants, as its own IRS returns show them.",
 "url": "https://sites.alleviate.org/index/funder/kaleidoscope-of-hope-foundation-inc-223744037",
 "source": {
  "name": "IRS returns",
  "form": "990",
  "periods": [
   "2024-12",
   "2023-12"
  ],
  "read": "2026-11-21"
 },
 "method": "https://sites.alleviate.org/index/method#funders",
 "funder": {
  "ein": "223744037",
  "name": "Kaleidoscope of Hope Foundation Inc",
  "kind": "grantmaking_public_charity",
  "form": "990",
  "city": "Madison",
  "state": "NJ",
  "country": "US",
  "latest_period": "2024-12",
  "assets_fmv_end": null,
  "giving": [
   {
    "period": "2024-12",
    "paid": 75000,
    "grants_listed": 3,
    "itemized": "itemized"
   },
   {
    "period": "2023-12",
    "paid": 152750,
    "grants_listed": 4,
    "itemized": "itemized"
   }
  ],
  "grants": {
   "latest_listed": 3,
   "median": 25000,
   "middle_half": [
    25000,
    25000
   ],
   "listed": 7,
   "linked": 2
  },
  "focus": [
   {
    "group": "B",
    "label": "Education",
    "share": 1
   }
  ],
  "states": [
   {
    "grants": 2,
    "state": "PA"
   },
   {
    "grants": 1,
    "state": "GA"
   },
   {
    "grants": 1,
    "state": "OH"
   },
   {
    "grants": 1,
    "state": "NJ"
   },
   {
    "grants": 1,
    "state": "TX"
   },
   {
    "grants": 1,
    "state": "NY"
   }
  ],
  "accepts_applications": null,
  "apply": null,
  "charity_profile": "https://sites.alleviate.org/index/org/kaleidoscope-of-hope-foundation-inc-223744037"
 },
 "recent_grants": [
  {
   "recipient": "CORPORATING MERCER UNIVERSITY",
   "recipient_url": null,
   "city": "MACON",
   "state": "GA",
   "country": "US",
   "period": "2024-12",
   "amount": 25000,
   "purpose": "TO SUPPORT OVARIAN CANCER RESEARCH",
   "form": "990"
  },
  {
   "recipient": "Ohio University Foundation",
   "recipient_url": "https://sites.alleviate.org/index/org/ohio-university-foundation-316402269",
   "city": "ATHENS",
   "state": "OH",
   "country": "US",
   "period": "2024-12",
   "amount": 25000,
   "purpose": "TO SUPPORT OVARIAN CANCER RESEARCH",
   "form": "990"
  },
  {
   "recipient": "TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA",
   "recipient_url": null,
   "city": "PHILADELPHIA",
   "state": "PA",
   "country": "US",
   "period": "2024-12",
   "amount": 25000,
   "purpose": "INVESTIGATION OF A NOVEL P53 STABILIZING TARGETED TREATMENT COMBINATION IN TP53 WILD TYPE OVARIAN CANCER.",
   "form": "990"
  },
  {
   "recipient": "TEMPLE UNIVERSITY - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION",
   "recipient_url": null,
   "city": "NEW YORK",
   "state": "NY",
   "country": "US",
   "period": "2023-12",
   "amount": 50000,
   "purpose": "UNDERSTANDING THE ROLE OF CARM 1 IN REGULATION OF CYTOKINE-MEDIATED ANTITUMOR RESPONSE IN OVARIAN CANCER.",
   "form": "990"
  },
  {
   "recipient": "TRUSTEES OF THE UNIVERISTY OF PENNSYLVANIA",
   "recipient_url": null,
   "city": "PHILADELPHIA",
   "state": "PA",
   "country": "US",
   "period": "2023-12",
   "amount": 50000,
   "purpose": "INVESTIGATION OF A NOVEL P53 STABILIZING TARGETED TREATMENT COMBINATION IN TP53 WILD TYPE OVARIAN CANCER.",
   "form": "990"
  },
  {
   "recipient": "The Trustees of the Stevens Institute of Technology",
   "recipient_url": "https://sites.alleviate.org/index/org/the-trustees-of-the-stevens-institute-of-technology-221487354",
   "city": "HOBOKEN",
   "state": "NJ",
   "country": "US",
   "period": "2023-12",
   "amount": 25000,
   "purpose": "NUTRITIONAL SUPPLEMENT TAURINE SUPPRESSES OVARIAN CANCER.",
   "form": "990"
  },
  {
   "recipient": "UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER",
   "recipient_url": null,
   "city": "HOUSTON",
   "state": "TX",
   "country": "US",
   "period": "2023-12",
   "amount": 25000,
   "purpose": "TO IDENTIFY LIQUID BIOPSY (EXTRACELLULAR VESICLES)BASED MOLECULAR PREDICTORS OF DISEASE PATTERNS FROM PATIENTS FROM MATCHED TISSUES AND BLOOD FROM PATIENTS WITH COMPLETE GROSS RESECTION AND PATIENTS WITH EXCELLENT AND POOR RESPONSE TO CHEMOTHERAPY, FOLLOWED BY CLINICAL VALLIDATION OF OUR FINDING IN PATIENTS WITH HIGHGRADE SEROUS OVARIAN CANCER.",
   "form": "990"
  }
 ]
}
